Public Service Enterprise Group is down 3% on the week and 8% over the past month, yet the most interesting signal right now is not the selling — it's the options market quietly shifting in the other direction.
The options picture has flipped from defensive to aggressive. The put/call ratio has dropped to 0.50, roughly 1.4 standard deviations below its 20-day average of 0.64. That's a meaningful lean toward calls, and it stands in sharp contrast to the price action. As recently as early August the PCR was running above 0.75 — at levels consistent with cautious hedging ahead of earnings. Since the August 4 print, that defensive positioning has unwound steadily. The 52-week PCR range runs from 0.20 to 5.69, so at 0.50 the ratio sits near the bullish end of its recent band, even if well away from the historical floor.
Short interest tells a low-conviction story on both sides. Bears hold roughly 1.9% of the free float — about 9.4 million shares — and that number has been falling. SI is down almost 5% on the week and 14% over the past month, a steady unwind rather than a sudden cover. The borrow market is completely uncrowded: availability is near the system cap, with almost 500 million shares available to lend against the 9.4 million currently borrowed. Cost to borrow has ticked up 36% on the week to 0.44%, but that figure is still firmly in penny-stock-rate territory and far from signalling any squeeze pressure. Positioning overall looks cautious rather than crowded — short sellers are stepping back, not piling in.
The Street has been cutting targets in one direction all month, but the ratings themselves haven't moved. Morgan Stanley trimmed to $91 from $93 this week while holding Overweight. Truist cut to $84 from $90 earlier in August. Citigroup and Wells Fargo both lowered targets by $6–7 after the Q2 print. The consensus target sits around $85.50 against a $73.28 price — roughly 17% implied upside — but that gap has been shrinking as analysts ratchet expectations down toward where the stock is actually trading. The bull case centres on a data-centre colocation contract, a growing large-load inquiry backlog (9.4 GW, up from 6.4 GW), and rate-base expansion. The bear case is simpler: higher rates pressure utility multiples, and management's data-centre deal pipeline appears to be narrowing. Forward earnings look constructive — the 12-month forward EPS growth rank is in the 89th percentile of the universe — but near-term momentum ranks in the bottom half, and the dividend score at the 97th percentile flags a stock trading increasingly on yield support rather than growth conviction.
PEG is not suffering alone. Close peers WEC and CNP are each down close to 4% on the week, AEE off about 2.6%, and SRE down 3.6%. The weakness is sector-wide, driven by rate sensitivity and rotation rather than anything company-specific. That context matters: if the selling is macro-led, the individual stock's story — large-load backlog, regulatory tailwinds, a still-intact Overweight from Morgan Stanley — remains intact underneath.
The Q2 print on August 4 delivered a modest negative reaction: the stock fell 1.4% the next day and extended that to about 1.8% over five sessions. The next earnings event is scheduled for November 3. Between now and then, the data-centre contract developments and any Federal Reserve language on rates are the variables most likely to determine whether the gap between the $73 price and the $85 consensus target begins to close or continues to narrow from the top down.
See the live data behind this article on ORTEX.
Open PEG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
